Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

788

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Plaque Psoriasis

Interventions

DRUG

M518101

8-week comparative treatment period ( twice daily application) followed by a maximum 8-week period to evaluate time to relapse

Trial Locations (6)

Universitätsklinik für Dermatologie und Venerologie,, Graz

"DCC Chaika EOOD", Varna

Universitatsklinikum Schleswig-Holstein, Lübeck

Semmelweis Hospital, Miskolc

PI Hospital of Lithuanian University of Health Sciences, Kaunas

CSK MON Wojskowego Instytutu Medycznego, Warsaw

All Listed Sponsors

collaborator

Maruho Co., Ltd.

INDUSTRY

lead

Maruho Europe Limited

INDUSTRY

NCT01989429 - Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients | Biotech Hunter | Biotech Hunter